What Is Kisspeptin-10? Uses, Benefits, Safety, FDA Status, and Evidence
Medical review note: This article is for educational purposes only and does not provide medical advice. Kisspeptin-10 is not FDA-approved for human therapeutic use. Products sold online as Kisspeptin-10, KP-10, metastin fragment, or “research use only” Kisspeptin-10 may carry safety, quality, legal, and anti-doping risks.
Quick answer
Kisspeptin-10 is a synthetic 10-amino-acid fragment of kisspeptin, a hormone system that regulates reproductive function by stimulating gonadotropin-releasing hormone, also called GnRH. GnRH then signals the pituitary gland to release luteinizing hormone, called LH, and follicle-stimulating hormone, called FSH. Human studies show that Kisspeptin-10 can increase LH secretion and reproductive-hormone signaling, including testosterone-related signaling in men, but it is not FDA-approved and has limited clinical-outcome evidence for fertility, testosterone optimization, libido, bodybuilding, or post-cycle therapy. FDA flags compounded Kisspeptin-10 as a safety-risk concern, and WADA prohibits kisspeptin and its agonist analogues for males.
Key facts about Kisspeptin-10
| Question | Answer |
|---|---|
| What is Kisspeptin-10? | A synthetic 10-amino-acid fragment of kisspeptin. |
| Other names | KP-10, kisspeptin-10, metastin fragment, KISS1 peptide fragment. |
| Peptide class | Reproductive hormone peptide / GnRH-stimulating peptide / kisspeptin receptor agonist. |
| Main mechanism | Activates kisspeptin receptor signaling upstream of GnRH, which can increase LH and FSH release. |
| FDA-approved? | No. Kisspeptin-10 is not an FDA-approved drug. |
| Main studied uses | Reproductive hormone stimulation, LH pulse regulation, fertility research, hypothalamic amenorrhea research, hypogonadism research, and sexual desire research. |
| Human evidence level | Limited to moderate human evidence for LH/GnRH-axis stimulation; weak evidence for broad fertility, testosterone optimization, libido, bodybuilding, or post-cycle therapy claims. |
| Animal/lab evidence level | Strong biological evidence that kisspeptin signaling is central to reproductive-axis regulation. |
| Common online claims | “Boosts LH,” “boosts testosterone,” “fertility peptide,” “libido peptide,” “HCG alternative,” “post-cycle therapy,” “restarts HPTA.” |
| Sports status | Prohibited by WADA for males as a testosterone-stimulating peptide category substance. |
| Main safety concern | Hormone-axis disruption, limited safety data for compounded routes, peptide impurity and API characterization concerns, and anti-doping prohibition for males. |
What is Kisspeptin-10?
Kisspeptin-10 is a short synthetic peptide derived from the kisspeptin family. Kisspeptins are encoded by the KISS1 gene and act through the kisspeptin receptor, often called KISS1R or GPR54.
Kisspeptin signaling is one of the key upstream regulators of the reproductive hormone axis. It helps stimulate GnRH release, which then drives LH and FSH secretion from the pituitary gland.
A PMC review on kisspeptin and reproductive endocrinology describes kisspeptin as a critical regulator of the reproductive axis through stimulation of hypothalamic GnRH release.
The FDA’s PCAC material describes Kisspeptin-10 as a synthetic peptide consisting of ten amino acids and states that kisspeptin is an upstream regulator of GnRH secretion, which initiates puberty, coordinates ovulation, and maintains reproductive function.
The key distinction:
Kisspeptin-10 is upstream of GnRH, LH, FSH, and sex-hormone signaling. That makes it biologically important, but not automatically safe, approved, or clinically proven for consumer hormone optimization.
How does Kisspeptin-10 work?
Kisspeptin-10 activates kisspeptin receptor signaling. This stimulates GnRH neurons, which increases GnRH release. GnRH then stimulates the anterior pituitary to release LH and FSH.
In plain English:
Kisspeptin-10 tells the hypothalamic-pituitary reproductive axis to turn on reproductive hormone signaling.
The simplified pathway looks like this:
| Step | Signal |
|---|---|
| 1 | Kisspeptin-10 activates kisspeptin receptors. |
| 2 | GnRH neurons are stimulated. |
| 3 | GnRH release increases. |
| 4 | Pituitary LH and FSH release increase. |
| 5 | Gonadal hormone and fertility pathways may be affected. |
A PMC human study reported that Kisspeptin-10 boluses potently evoked LH secretion in men and that continuous infusion increased testosterone, LH pulse frequency, and LH pulse size.
But mechanism is not proof.
A proposed LH, FSH, or testosterone mechanism does not prove that Kisspeptin-10 safely treats infertility, boosts testosterone in healthy men, improves libido, replaces HCG, restores anabolic-steroid suppression, or works as a general hormone-optimization peptide.
What is Kisspeptin-10 used for?
Kisspeptin-10 is commonly discussed for reproductive hormones, fertility, testosterone, libido, ovulation, hypothalamic amenorrhea, and post-cycle therapy. These uses differ sharply in evidence quality.
| Use | Evidence level | What is known | What is not known | |---|---|---| | LH stimulation | Human evidence | Kisspeptin-10 can increase LH secretion in men and women. | Long-term clinical utility and safety for consumer use are not established. | | FSH stimulation | Human evidence | Human studies show reproductive-hormone effects including FSH changes in some contexts. | Effects vary by sex, cycle phase, endocrine state, and dosing. | | Testosterone signaling | Limited human evidence | Studies in men show increased LH and testosterone-related signaling. | Not proven as a general testosterone optimization drug. | | Hypogonadism research | Early / limited human evidence | Studies have evaluated hypotestosteronemic men and endocrine responses. | Not FDA-approved for hypogonadism. | | Fertility research | Clinical research evidence | Kisspeptin biology is relevant to ovulation and reproductive function. | It is not a broadly approved fertility medication. | | Hypothalamic amenorrhea research | Clinical research evidence | Kisspeptin has been studied in hypothalamic amenorrhea and reproductive-axis suppression. | Approved treatment role is not established. | | Libido / sexual desire | Early human research | Kisspeptin has been studied in hypoactive sexual desire disorder. | It is not an FDA-approved libido drug. | | Post-cycle therapy | Unsupported as broad use | Online use is marketed after anabolic steroid cycles. | Strong clinical evidence for PCT is lacking, and use is prohibited in males under WADA. | | Online research-use Kisspeptin-10 | High uncertainty | Sellers market it as a peptide product. | Quality, sterility, identity, dose, and legal status may be unknown. |
What does the research show?
Human evidence for LH and testosterone signaling
The strongest human evidence supports a narrow claim:
Kisspeptin-10 can stimulate reproductive-hormone signaling, especially LH release.
A PubMed-indexed study in men reported that Kisspeptin-10 boluses evoked LH secretion and that continuous infusion increased testosterone, LH pulse frequency, and LH pulse size.
A PMC version of the same study states that Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men.
A PubMed-indexed study in healthy men and women reported that intravenous Kisspeptin-10 elevated serum LH and FSH in healthy men and also increased reproductive hormones in healthy women.
The practical interpretation:
Kisspeptin-10 has real human endocrine activity. It is not fake. But hormone stimulation is not the same as proven treatment benefit.
Human evidence in hypotestosteronemic men
Kisspeptin-10 has been studied in men with low testosterone in the context of type 2 diabetes.
A PubMed-indexed proof-of-concept study reported that Kisspeptin-10 increased LH pulse frequency and LH secretion in hypotestosteronemic men with type 2 diabetes.
The practical interpretation:
Kisspeptin-10 may stimulate upstream reproductive hormone signaling in some men with low testosterone states, but it is not an FDA-approved testosterone therapy or universal testosterone booster.
Human evidence in fertility and reproductive medicine
Kisspeptin research is important in reproductive medicine.
A PMC direct-comparison study compared intravenous kisspeptin-10, kisspeptin-54, and GnRH in healthy men. The study reported that kisspeptin-10 and kisspeptin-54 produced similar gonadotropin secretion, while GnRH was more potent.
A JAMA Network Open randomized clinical trial studied kisspeptin administration in men with hypoactive sexual desire disorder and evaluated hormonal, behavioral, and neural responses.
The practical interpretation:
Kisspeptin is a serious reproductive-neuroendocrine research target, but current evidence does not justify broad wellness-clinic claims.
FDA safety and compounding context
FDA has specifically flagged Kisspeptin-10 in the compounding-risk context.
The FDA page on bulk drug substances that may present significant safety risks states that compounded drugs containing Kisspeptin-10 may pose immunogenicity risk for certain routes of administration and may have complexities related to peptide impurities and active pharmaceutical ingredient characterization. FDA also states that it has no, or only limited, safety-related information for proposed routes of administration and lacks sufficient information to know whether the drug would cause harm when administered to humans.
The practical interpretation:
Kisspeptin-10 should not be treated as a harmless hormone peptide. FDA has identified real safety-data and product-characterization concerns.
Evidence summary
| Claim | Evidence verdict | Explanation |
|---|---|---|
| “Kisspeptin-10 stimulates LH.” | Supported | Human studies show Kisspeptin-10 can increase LH secretion. |
| “Kisspeptin-10 can affect FSH.” | Supported in human endocrine studies | Effects depend on sex, endocrine state, cycle phase, and dosing. |
| “Kisspeptin-10 increases testosterone in men.” | Supported in limited human studies | Studies show testosterone-related signaling increases, but this is not proof of broad therapeutic benefit. |
| “Kisspeptin-10 is FDA-approved.” | False | Kisspeptin-10 is not an FDA-approved drug. |
| “Kisspeptin-10 treats low testosterone.” | Not established | It is not FDA-approved for hypogonadism or testosterone optimization. |
| “Kisspeptin-10 treats infertility.” | Not established as a broad claim | Kisspeptin biology is important to fertility, but Kisspeptin-10 is not a general approved fertility drug. |
| “Kisspeptin-10 replaces HCG.” | False as a simple claim | Kisspeptin-10 works upstream of GnRH/LH/FSH; HCG acts more directly like LH at the gonads. |
| “Kisspeptin-10 is good for PCT.” | Unsupported | Post-cycle therapy claims are not supported by strong clinical evidence. |
| “Kisspeptin-10 is allowed for male athletes.” | False | WADA prohibits kisspeptin and its agonist analogues for males. |
| “Research-use Kisspeptin-10 is clinically proven.” | False | Research-use products are not FDA-approved consumer therapeutic products. |
Is Kisspeptin-10 FDA-approved?
No. Kisspeptin-10 is not FDA-approved.
The FDA has placed Kisspeptin-10 in a category of bulk drug substances used in compounding that may present significant safety risks. FDA states that compounded Kisspeptin-10 may pose immunogenicity risk for certain routes of administration and may involve peptide-related impurity and API characterization challenges.
The key distinction:
Kisspeptin-10 is a biologically active reproductive-axis peptide, not an FDA-approved prescription medication.
Is Kisspeptin-10 legal?
Kisspeptin-10’s legal status depends on product type, intended use, jurisdiction, and how it is sold.
The practical answer is simple:
Kisspeptin-10 is not an FDA-approved drug, and online availability does not mean it is legally marketed for human therapeutic use.
Some sellers market Kisspeptin-10 as a research peptide. That does not make it safe, approved, legal, or appropriate for consumer use.
The blunt version:
Buying “research use only” Kisspeptin-10 online is not the same as receiving an FDA-approved prescription medication from a legitimate pharmacy.
Is Kisspeptin-10 banned in sports?
Yes, for males under WADA’s testosterone-stimulating peptide category.
The WADA 2026 Prohibited List lists testosterone-stimulating peptides in males, including kisspeptin and its agonist analogues.
For athletes, the practical answer is:
Male athletes subject to WADA rules should not use Kisspeptin-10 unless a valid therapeutic-use exemption or official anti-doping pathway applies.
Safety and side effects
Kisspeptin-10 is hormone-active. It should not be treated like a harmless supplement.
Possible or theoretical concerns include:
- Headache
- Flushing
- Nausea
- Abdominal discomfort
- Injection-site reactions
- Hormonal changes
- LH and FSH changes
- Testosterone changes in men
- Menstrual-cycle effects in women
- Fertility-axis disruption
- Puberty-axis effects
- Unknown long-term safety
- Immunogenicity risk
- Peptide-related impurities
- Active pharmaceutical ingredient characterization concerns
- Product-quality and sterility risks from online sellers
- Anti-doping consequences for male athletes
The FDA specifically states that safety-related information for proposed routes of administration is no or limited and that FDA lacks sufficient information to know whether compounded Kisspeptin-10 would cause harm when administered to humans.
A serious evaluation of Kisspeptin-10 should separate controlled reproductive-endocrine research from online hormone-optimization use.
Kisspeptin-10 vs similar peptides and hormones
| Compound | Category | Main difference |
|---|---|---|
| Kisspeptin-10 | Kisspeptin receptor agonist / GnRH-axis stimulant | Acts upstream by stimulating GnRH signaling. |
| Kisspeptin-54 | Longer kisspeptin peptide | Also stimulates kisspeptin receptor signaling; studied in reproductive medicine. |
| Gonadorelin | GnRH | Directly stimulates pituitary LH and FSH release. |
| HCG | Gonadotropin / LH-like signal | Acts more directly on the gonads through LH-like signaling. |
| LH | Pituitary gonadotropin | Direct endogenous signal from pituitary to gonads. |
| FSH | Pituitary gonadotropin | Supports ovarian follicle development and spermatogenesis. |
| Clomiphene | SERM | Indirectly increases GnRH/LH/FSH by blocking estrogen feedback. |
| Enclomiphene | SERM isomer | Similar endocrine logic to clomiphene, but different compound. |
| Testosterone | Androgen | Supplies testosterone directly and can suppress endogenous LH/FSH. |
The key distinction:
Kisspeptin-10 works upstream of GnRH. Gonadorelin is GnRH. HCG acts more downstream at the gonads. Testosterone is direct hormone replacement. They are not interchangeable.
Why is Kisspeptin-10 sold as “research use only”?
Some online sellers use “research use only” language to sell Kisspeptin-10 outside normal prescription-drug channels.
That label is not a trust signal.
A serious reader should understand this distinction:
| Product type | What it means |
|---|---|
| Laboratory Kisspeptin-10 | Research peptide used in controlled experimental settings. |
| FDA-approved Kisspeptin-10 | Does not currently exist. |
| Compounded Kisspeptin-10 | FDA has raised safety and characterization concerns. |
| Research-use Kisspeptin-10 | Not an FDA-approved consumer therapeutic product. |
| Online peptide Kisspeptin-10 | Higher risk for identity, sterility, dosing, and quality problems. |
How to evaluate Kisspeptin-10 claims online
| Claim | What to verify |
|---|---|
| “FDA-approved Kisspeptin-10” | False. Kisspeptin-10 is not FDA-approved. |
| “Boosts testosterone” | Check whether the claim is based on diagnosed endocrine dysfunction or generic hormone optimization marketing. |
| “HCG replacement” | False as a simple claim. Kisspeptin-10 and HCG act at different levels of the reproductive axis. |
| “Post-cycle therapy peptide” | Look for controlled human evidence, not bodybuilding anecdotes. |
| “Restores fertility” | Only plausible in specific endocrine contexts; it is not a universal fertility treatment. |
| “Works for all low testosterone” | False. Effects depend on hypothalamic, pituitary, and gonadal function. |
| “No side effects” | False. It is hormone-active and FDA has flagged safety-data limitations. |
| “Research use only” | This does not mean safe, legal, approved, or appropriate for human use. |
| “Safe for athletes” | False for males subject to WADA rules. Kisspeptin and agonist analogues are listed as prohibited. |
| “Third-party tested” | Ask for batch-specific HPLC, LC-MS, identity, purity, sterility, endotoxin, and stability data. |
Bottom line
Kisspeptin-10 is a synthetic 10-amino-acid kisspeptin fragment that stimulates reproductive hormone signaling upstream of GnRH, LH, and FSH. Human studies show that it can increase LH secretion and affect reproductive-hormone signaling, including testosterone-related signaling in men.
The most defensible conclusion is:
Kisspeptin-10 is a real reproductive-endocrine research peptide, not a casual testosterone booster. It is not FDA-approved, FDA has flagged compounded Kisspeptin-10 as a safety-risk concern, online hormone-optimization claims often go beyond the evidence, and WADA prohibits kisspeptin and its agonist analogues for males in sport.
FAQ
What is Kisspeptin-10?
Kisspeptin-10 is a synthetic 10-amino-acid fragment of kisspeptin, a hormone system that regulates GnRH, LH, FSH, and reproductive function.
What does Kisspeptin-10 do?
Kisspeptin-10 stimulates kisspeptin receptor signaling upstream of GnRH. This can increase LH and FSH release and may affect reproductive hormone signaling.
Is Kisspeptin-10 FDA-approved?
No. Kisspeptin-10 is not FDA-approved. FDA has flagged compounded Kisspeptin-10 for possible immunogenicity, peptide impurity, API characterization concerns, and limited safety-related information.
Does Kisspeptin-10 increase testosterone?
Kisspeptin-10 can increase LH signaling and has increased testosterone-related signaling in some human studies. It is not FDA-approved as a testosterone therapy or general testosterone booster.
Is Kisspeptin-10 the same as gonadorelin?
No. Kisspeptin-10 acts upstream by stimulating GnRH signaling. Gonadorelin is synthetic GnRH itself.
Is Kisspeptin-10 the same as HCG?
No. Kisspeptin-10 acts upstream of GnRH and LH. HCG acts more directly like LH at the gonads.
Does Kisspeptin-10 help fertility?
Kisspeptin biology is important for reproductive function, and kisspeptin peptides are studied in fertility research. However, Kisspeptin-10 is not an FDA-approved general fertility treatment.
Is Kisspeptin-10 used for post-cycle therapy?
Kisspeptin-10 is marketed online for post-cycle therapy, but strong clinical evidence for broad PCT use is lacking. It is also prohibited for males under WADA rules.
Is Kisspeptin-10 safe?
Kisspeptin-10 does not have enough long-term human safety data to call it safe for consumer use. FDA has raised concerns about immunogenicity, peptide impurities, API characterization, and limited safety information.
Is Kisspeptin-10 banned in sports?
Yes, for males. WADA lists kisspeptin and its agonist analogues as prohibited testosterone-stimulating peptides in males.
Why do sellers call Kisspeptin-10 “research use only”?
Sellers often use “research use only” language because Kisspeptin-10 is not FDA-approved for consumer therapeutic use. The phrase does not make the product safe, legal, approved, or clinically proven.
What is the biggest risk with Kisspeptin-10?
The biggest risks are using a hormone-active investigational peptide without proper endocrine diagnosis, assuming it works like HCG or testosterone, buying online products with uncertain quality, and violating anti-doping rules.
Sources
- FDA: Certain Bulk Drug Substances for Use in Compounding May Present Significant Safety Risks
- FDA: October 29, 2024 Pharmacy Compounding Advisory Committee Meeting Material
- PubMed: Kisspeptin-10 Is a Potent Stimulator of LH and Increases Pulse Frequency in Men
- PMC: Kisspeptin-10 Is a Potent Stimulator of LH and Increases Pulse Frequency in Men
- PubMed: The Effects of Kisspeptin-10 on Reproductive Hormone Release in Healthy Men and Women
- PMC: The Effects of Kisspeptin-10 on Reproductive Hormone Release in Healthy Men and Women
- PubMed: Kisspeptin-10 Stimulates Serum Testosterone and LH Secretion in Hypotestosteronemic Men with Type 2 Diabetes
- PMC: Direct Comparison of Intravenous Kisspeptin-10, Kisspeptin-54, and GnRH
- PMC: Comprehensive Review on Kisspeptin and Its Role in Reproductive Disorders
- JAMA Network Open: Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men with Hypoactive Sexual Desire Disorder
- WADA: 2026 Prohibited List
- WADA: Prohibited List
Frequently asked questions
What is Kisspeptin-10?
Kisspeptin-10 is a synthetic 10-amino-acid fragment of kisspeptin, a hormone system that regulates GnRH, LH, FSH, and reproductive function.
Is Kisspeptin-10 FDA-approved?
No. Kisspeptin-10 is not FDA-approved. FDA has flagged compounded Kisspeptin-10 for possible immunogenicity, peptide impurity, API characterization concerns, and limited safety-related information.
Does Kisspeptin-10 increase testosterone?
Kisspeptin-10 can increase LH signaling and has increased testosterone-related signaling in some human studies. It is not FDA-approved as a testosterone therapy or general testosterone booster.
Is Kisspeptin-10 the same as gonadorelin?
No. Kisspeptin-10 acts upstream by stimulating GnRH signaling. Gonadorelin is synthetic GnRH itself.
Is Kisspeptin-10 the same as HCG?
No. Kisspeptin-10 acts upstream of GnRH and LH. HCG acts more directly like LH at the gonads.
Is Kisspeptin-10 safe?
Kisspeptin-10 does not have enough long-term human safety data to call it safe for consumer use. FDA has raised concerns about immunogenicity, peptide impurities, API characterization, and limited safety information.
Is Kisspeptin-10 banned in sports?
Yes, for males. WADA lists kisspeptin and its agonist analogues as prohibited testosterone-stimulating peptides in males.
Sources
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]WADA: 2026 Prohibited List
Anti Doping
- [12]WADA: Prohibited List
Anti Doping
Last updated May 9, 2026